Compound/drug and conc. | Mean motility scores over a period of 40 days | Motility | MTT | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
DAY | 1 | 5 | 10 | 15 | 20 | 25 | 30 | 35 | 40 | % reduction on day 40 (P) | % inhibition on day 40 (P) |
Control | 7.6 | 7.2 | 7.1 | 6.8 | 5.9 | 4.9 | 5.8 | 6.1 | 6.3 | Â | Â |
aCGP 6140 1.25 × 10-5M (positive control) | 1.3 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 (ND) | 87.2 (ND) |
bNorfloxacin 5 × 10-5M | 6.9 | 7.4 | 7.1 | 2.4 | 2.5 | 2.6 | 1.4 | 1.0 | 2.5 | 60.3 (ND) | 90.7 (ND) |
Ciprofloxacin 5 × 10-5M | 6.9 | 7.9 | 7.1 | 3.6 | 4.1 | 3.0 | 2.3 | 2.5 | 3.0 | 52.4 (0.080) | 73.3 (0.040) |
Vancomycin 5 × 10-5M | 6.4 | 7.4 | 6.5 | 3.6 | 3.6 | 2.8 | 2.4 | 1.6 | 2.1 | 66.7 (0.009) | 83.7 (0.022) |
Gentamycin 5 × 10-5M | 7.6 | 5.5 | 6.3 | 2.8 | 2.6 | 0.8 | 1.5 | 1.0 | 1.6 | 74.6 (0.005) | 83.7 (0.017) |
Ceftriaxone 5 × 10-5M | 7.1 | 6.8 | 7.0 | 2.4 | 2.0 | 0.9 | 0.6 | 0.6 | 0.7 | 88.9 (<0.001) | 90.7 (0.011) |
cTriclosan 5 × 10-5M | 6.9 | 4.9 | 0.4 | 0.1 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 (ND) | 98.8 (ND) |
cCerulenin 5 × 10-5M | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 100.0 (ND) | 100.0 (ND) |